PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Prestige Consumer Healthcare Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$49.71−0.21 (-0.42%)
Close on Oct 19, 2026
- Market cap
- $2.37B
- P/E (TTM)
- 13.9
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$2.02B
$10.45M due within a year
Net debt
$1.93B
After $89.13M of cash
Implied interest rate
–
FY2026 interest ÷ average debt
Interest coverage
–
FY2026 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Prestige Consumer Healthcare's annual report. Trading prices and yields need FINRA TRACE data.